Clinical trials
Esophageal Neoplasms trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 7 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Lille | 4 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 2 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 2 |
| Société Française d'Endoscopie Digestive | 2 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Leon Berard | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hospices Civils de Lyon | 1 |
| IHU Strasbourg | 1 |
| University Hospital, Antwerp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 16 |
| Stomach Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Rectal Neoplasms | 3 |
| Kidney Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.